Abstract：Objective To investigate the value of the Chinese visceral adiposity index (CVAI) in predicting hypertension risk, so as to provide a tool for the early assessment of hypertension risk. Methods Health examination individuals aged ≥18 years were selected from four medical institutes in Jinhua City, Zhejiang Province in 2022. Data on basic information, lifestyle, disease history, body mass index, waist circumference, blood pressure, and blood biochemical indicators were collected through questionnaire surveys and physical examinations. CVAI was calculated to assess levels of visceral fat accumulation, divided by quartiles into Q1, Q2, Q3, and Q4 groups. The relationship between CVAI and hypertension was analyzed using a multivariable logistic regression model, and their dose-response relationship was examined using a restricted cubic spline model. The value of CVAI in predicting hypertension risk was evaluated using receiver operating characteristic (ROC) curve. Results A total of 23 791 individuals were enrolled, with a median age of 68.00 (interquartile range, 14.00) years. Among them, 10 178 (42.78%) were males and 13 613 (57.22%) were females. The median CVAI was 111.40 (interquartile range, 48.23). Hypertension was identified in 15 563 cases, with a prevalence of 65.42%. After adjusting for lifestyle, disease history, and blood biochemical indicators, the multivariable logistic regression analysis revealed that hypertension risk in the CVAI Q2, Q3, and Q4 groups were 2.012 (95%CI: 1.865-2.170), 3.059 (95%CI: 2.826-3.311), and 5.099 (95%CI: 4.672-5.565) times that of the Q1 group, respectively. The restricted cubic spline model revealed a non-linear relationship between CVAI and hypertension risk (Pnon linearity<0.05). Hypertension risk increased more rapidly when the CVAI was ≥81.03. The area under the ROC curve for CVAI in predicting hypertension risk was 0.691, with an optimal cutoff value of 106.01, which falls within the Q2 group. Conclusions There was a nonlinear dose-response relationship between CVAI and hypertension. CVAI can predict the risk of hypertension, and 106.01 can serve as an early warning threshold for risk screening.
[1] 王盼,张晓晗,黄涛.成年人收缩压与尿酸、血脂、血糖的关联研究[J].预防医学,2023,35(9):746-751. WANG P,ZHANG X H,HUANG T.Correlations of systolic blood pressure with uric acid,blood lipid and blood glucose[J].China Prev Med J,2023,35(9):746-751.(in Chinese) [2] 刘明波,何新叶,杨晓红,等.《中国心血管健康与疾病报告2024》要点解读[J].临床心血管病杂志,2025,41(7):492-511. LIU M B,HE X Y,YANG X H,et al.Interpretation of Annual Report on Cardiovascular Health and Diseases in China 2024[J].J Clin Cardiol,2025,41(7):492-511.(in Chinese) [3] 中华人民共和国国家卫生健康委员会.中国居民营养与慢性病状况报告(2020年)[J].营养学报,2020,42(6):521. National Health Commission of the People's Republic of China.Report on nutrition and chronic diseases status of Chinese residents(2020)[J].Acta Nutr Sin,2020,42(6):521.(in Chinese) [4] 王亮亮,黄瑜,郭伟,等.肥胖和中心性肥胖对高血压的交互作用分析[J].预防医学,2022,34(2):129-134. WANG L L,HUANG Y,GUO W,et al.Transactional analysis of obesity and central obesity on hypertension[J].China Prev Med J,2022,34(2):129-134.(in Chinese) [5] XIA M F,CHEN Y,LIN H D,et al.A indicator of visceral adipose dysfunction to evaluate metabolic health in adult Chinese[J/OL].Sci Rep,2016,6[2025-10-24].https://doi.org/10.1038/srep38214. [6] GAO D T,CHEN X J,LIU D C,et al.Association between Chinese visceral adiposity index and risk of incident hypertension among older adults:a prospective cohort study[J].High Blood Press Cardiovasc Prev,2025,32(5):553-562. [7] LI L L,XI L Q,WANG Q H.Association between Chinese visceral adiposity index and risk of new-onset hypertension in middle-aged and older adults with prediabetes:evidence from a large national cohort study[J/OL].Front Public Health,2025,13[2025-10-24].https://doi.org/10.3389/fpubh.2025.1509898. [8] 中国高血压防治指南修订委员会,高血压联盟(中国),中国医疗保健国际交流促进会高血压分会,等.中国高血压防治指南(2024年修订版)[J].中华高血压杂志(中英文),2024,32(7):603-700. Revision Committee of Chinese Guidelines for the Prevention and Treatment of Hypertension,Hypertension League of China,Hypertension Branch of China International Exchange and Promotion Association for Medical and Health Care,et al.Chinese guidelines for the prevention and treatment of hypertension(2024 revised edition)[J].Chin J Hypertens,2024,32(7):603-700.(in Chinese) [9] LI B Q,WANG J,ZHOU X,et al.Chinese visceral adiposity index is more closely associated with hypertension and prehypertension than traditional adiposity indices in Chinese population:results from the REACTION study[J/OL].Front Endocrinol,2022,13[2025-10-24].https://doi.org/10.3389/fendo.2022.921997. [10] 钱涛铭,刘莉,韩宇博,等.中老年人中国内脏肥胖指数与新发高血压剂量-反应关系[J].现代预防医学,2023,50(11):1927-1931. QIAN T M,LIU L,HAN Y B,et al.Dose-response relationship between visceral obesity index and new hypertension in middle-aged and elderly people[J].Mod Prev Med,2023,50(11):1927-1931.(in Chinese) [11] 马秋阳,钱航,付君,等.中国内脏脂肪指数对高血压发生风险的预测价值[J].湖北医药学院学报,2023,42(5):515-520. MA Q Y,QIAN H,FU J,et al.Predictive value of visceral adiposity index for the risk of developing hypertension[J].J Hubei Univ Med,2023,42(5):515-520.(in Chinese) [12] CAROBBIO S,PELLEGRINELLI V,VIDAL-PUIG A.Adipose tissue dysfunction determines lipotoxicity and triggers the metabolic syndrome:current challenges and clinical perspectives[J].Adv Exp Med Biol,2024,1460:231-272. [13] 何向阳,刘峥,徐英,等.肥胖与四种常见慢性病的相关性分析[J].预防医学,2020,32(7):692-697. HE X Y,LIU Z,XU Y,et al.Correlation between obesity and four common chronic diseases[J].China Prev Med J,2020,32(7):692-697.(in Chinese) [14] RANA M N,NEELAND I J.Adipose tissue inflammation and cardiovascular disease:an update[J].Curr Diab Rep,2022,22(1):27-37. [15] LEI X T,QIU S,YANG G Y,et al.Adiponectin and metabolic cardiovascular diseases:therapeutic opportunities and challenges[J].Genes Dis,2023,10(4):1525-1536. [16] LINDHORST A,RAULIEN N,WIEGHOFER P,et al.Adipocyte death triggers a pro-inflammatory response and induces metabolic activation of resident macrophages[J/OL].Cell Death Dis,2021,12[2025-10-24].https://doi.org/10.1038/s41419-021-03872-9. [17] JAYEDI A,RAHIMI K,BAUTISTA L E,et al.Inflammation markers and risk of developing hypertension:a meta-analysis of cohort studies[J].Heart,2019,105(9):686-692.
